Skip to Main Content

Paper Details

Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project.
Am J Hum Genet
7
2023
cancer, genetic risk variants, infants, monogenic, monogenic disease, uMDRs
Author NameAffiliation
Robert C GreenBroad Institute of MIT and Harvard, USA Harvard Medical School
Casie A GenettiManton Center for Orphan Disease Research, Boston Children's Hospital
Timothy W YuHarvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital
Timothy W YuHarvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital
Matthew S LeboBroad Institute of MIT and Harvard, USA Harvard Medical School, Brigham and Women's Hospital
Stacey PereiraCenter for Medical Ethics and Health Policy, Baylor College of Medicine Houston
Pankaj B AgrawalHarvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital, University of Miami Miller School of Medicine and Holtz Children's Hospital
Amy L McGuireCenter for Medical Ethics and Health Policy, Baylor College of Medicine Houston
Kurt D ChristensenHarvard Medical School, Harvard Pilgrim Health Care Institute
Heidi L RehmBroad Institute of MIT and Harvard, USA Harvard Medical School, USA Center for Genomic Medicine, Massachusetts General Hospital
Heidi L RehmBroad Institute of MIT and Harvard, USA Harvard Medical School, USA Center for Genomic Medicine, Massachusetts General Hospital
Ingrid A HolmHarvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital
Ingrid A HolmHarvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital
Alan H BeggsBroad Institute of MIT and Harvard, USA Harvard Medical School, Manton Center for Orphan Disease Research, Boston Children's Hospital
  • 1 - 14

Datasets